
DBV Technologies raises $50M via At-The-Market ADS placement on Nasdaq to fund allergy treatment development.
DBV Technologies announced a $50 million capital raise through the issuance of new American Depositary Shares (ADS) under its At-The-Market (ATM) program on Nasdaq. The placement involves issuing 3.66 million ADS, each representing five ordinary shar...


